Menarini Biotech
Lavinia Nardinocchi is an experienced specialist in UPD and cell line development at Menarini Biotech since September 2015, previously serving as a USP research laboratory technician. Prior experience includes a role as a Ricercatrice at IDI Istituto Dermopatico Immacolata from April 2011 to December 2014, and at Istituto Tumori "Regina Elena" from June 2006 to February 2011. Lavinia Nardinocchi holds a Dottorato di Ricerca in Medicina Molecolare from Sapienza Università di Roma (2007-2010), a Master's degree in Medical, Molecular and Cellular Biotechnology from Universita’ “La Sapienza” (2003-2005), a Bachelor's degree in Biotechnology from Sapienza Università di Roma (2000-2003), and a Maturità Classica from Liceo Classico "Antonio Meucci" di Aprilia (1995-2000).
This person is not in the org chart
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.